Literature DB >> 26676147

Perinatal Considerations in Women With Previous Diagnosis of Cancer.

Alejandro Landa1, Jeffrey Kuller2, Eleanor Rhee3.   

Abstract

As the average age that women have their first child increases and cancer therapies improve survival, obstetricians are more likely to care for pregnant women who have survived cancer. Managing these pregnancies can be challenging, as they may be associated with higher risks of maternal and neonatal morbidity and mortality. Different types of cancer require different types of intervention, including surgery, chemotherapy, radiation, or combinations of these. Prior cancer treatments therefore present different potential complications during pregnancy. Although for most women who survive cancer carrying a pregnancy does not seem to increase mortality rates, there are some associated neonatal morbidities. The most common perinatal complication associated with pregnancy after cancer is prematurity. Women who desire pregnancy after cancer survival should not be discouraged, but appropriate counseling and follow-up should be provided.

Entities:  

Mesh:

Year:  2015        PMID: 26676147     DOI: 10.1097/OGX.0000000000000255

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  2 in total

1.  Japan Society of Clinical Oncology Clinical Practice Guidelines 2017 for fertility preservation in childhood, adolescent, and young adult cancer patients: part 1.

Authors:  Miyuki Harada; Fuminori Kimura; Yasushi Takai; Takeshi Nakajima; Kimio Ushijima; Hiroaki Kobayashi; Toyomi Satoh; Akiko Tozawa; Kohei Sugimoto; Shigehira Saji; Chikako Shimizu; Kyoko Akiyama; Hiroko Bando; Akira Kuwahara; Tatsuro Furui; Hiroshi Okada; Koji Kawai; Nobuo Shinohara; Koichi Nagao; Michio Kitajima; Souichi Suenobu; Toshinori Soejima; Mitsuru Miyachi; Yoko Miyoshi; Akihiro Yoneda; Akihito Horie; Yasushi Ishida; Noriko Usui; Yoshinobu Kanda; Nobuharu Fujii; Makoto Endo; Robert Nakayama; Manabu Hoshi; Tsukasa Yonemoto; Chikako Kiyotani; Natsuko Okita; Eishi Baba; Manabu Muto; Iwaho Kikuchi; Ken-Ichirou Morishige; Koichiro Tsugawa; Hiroyuki Nishiyama; Hajime Hosoi; Mitsune Tanimoto; Akira Kawai; Kazuhiko Sugiyama; Narikazu Boku; Masato Yonemura; Naoko Hayashi; Daisuke Aoki; Yutaka Osuga; Nao Suzuki
Journal:  Int J Clin Oncol       Date:  2022-01-01       Impact factor: 3.402

2.  Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity.

Authors:  Yuji Tanaka; Fuminori Kimura; Luyi Zheng; Shoji Kaku; Akie Takebayashi; Kyoko Kasahara; Shunichiro Tsuji; Takashi Murakami
Journal:  Exp Anim       Date:  2018-06-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.